| Dr Rebecca Elizabeth Lozano, MD | |
|
2500 Merced St, San Leandro, CA 94577-4201 | |
| (510) 454-1000 | |
| Not Available |
| Full Name | Dr Rebecca Elizabeth Lozano |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 2500 Merced St, San Leandro, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982164067 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A180652 (California) | Primary |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
An examination of the world-wide use of hematopoietic stem cell transplantation, which involves transplantation of blood stem cells derived from the bone marrow or blood, finds that there are significant differences in transplant rates between countries and continental regions by indication and donor type, and that HSCT is most frequently used in countries with higher gross national incomes and governmental health care expenditures, according to a study in the April 28 issue of JAMA.
In October, an interdisciplinary group of scientists proposed forming a Unified Microbiome Initiative (UMI) to explore the world of microorganisms that are central to life on Earth and yet largely remain a mystery. An article in the journal ACS Nano describes the tools scientists will need to understand how microbes interact with each other and with us.
A novel study published in Restorative Neurology and Neuroscience provides the first evidence that a simple and inexpensive non-invasive speech-to-touch sensory substitution device has the potential to improve hearing in hearing-impaired cochlear implant patients, as well as individuals with normal hearing, to better discern speech in various situations like learning a second language or trying to deal with the "cocktail party effect."
ImmunGene, Inc., a biotechnology company focused on developing antibody-cytokine fusion technology therapies to treat cancer, today announced it has secured $9 million in a milestone-based Series A financing from Ally Bridge Group. Previous investments in the Company were converted into Series A preferred stock. ImmunGene will use the capital to advance its early-stage development products to IND-enabling studies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rebecca Elizabeth Lozano, MD 500 Parnassus Ave Rm M24, San Francisco, CA 94143-2203 Ph: (415) 353-1529 | Dr Rebecca Elizabeth Lozano, MD 2500 Merced St, San Leandro, CA 94577-4201 Ph: (510) 454-1000 |
News Archive
An examination of the world-wide use of hematopoietic stem cell transplantation, which involves transplantation of blood stem cells derived from the bone marrow or blood, finds that there are significant differences in transplant rates between countries and continental regions by indication and donor type, and that HSCT is most frequently used in countries with higher gross national incomes and governmental health care expenditures, according to a study in the April 28 issue of JAMA.
In October, an interdisciplinary group of scientists proposed forming a Unified Microbiome Initiative (UMI) to explore the world of microorganisms that are central to life on Earth and yet largely remain a mystery. An article in the journal ACS Nano describes the tools scientists will need to understand how microbes interact with each other and with us.
A novel study published in Restorative Neurology and Neuroscience provides the first evidence that a simple and inexpensive non-invasive speech-to-touch sensory substitution device has the potential to improve hearing in hearing-impaired cochlear implant patients, as well as individuals with normal hearing, to better discern speech in various situations like learning a second language or trying to deal with the "cocktail party effect."
ImmunGene, Inc., a biotechnology company focused on developing antibody-cytokine fusion technology therapies to treat cancer, today announced it has secured $9 million in a milestone-based Series A financing from Ally Bridge Group. Previous investments in the Company were converted into Series A preferred stock. ImmunGene will use the capital to advance its early-stage development products to IND-enabling studies.
› Verified 9 days ago
Chin-hsiang Feng, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-518-5598 | |
Dr. Grace Mindy Lee, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-454-1000 Fax: 203-688-5599 | |
Dr. Vibha Kundi Gupta, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 517-648-0339 | |
Allison Boyd, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-454-1000 | |
Dr. Bing Chung Shen, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-454-1000 | |
Anthony Michael Montefusco Iv, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 13855 E 14th St, San Leandro, CA 94578 Phone: 209-342-2300 Fax: 209-524-4240 | |
Mark Makoto Tanaka, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-454-1000 |